PFIZER CENTERONE Trademark

Trademark Overview

On Wednesday, February 3, 2016, a trademark application was filed for PFIZER CENTERONE with the United States Patent and Trademark Office. The USPTO has given the PFIZER CENTERONE trademark a serial number of 86895971. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, February 28, 2023. This trademark is owned by Pfizer Inc.. The PFIZER CENTERONE trademark is filed in the Treatment & Processing of Materials Services category with the following description:

Contract manufacturing services in the field of pharmaceuticals and pharmaceutical delivery systems
pfizer centerone

General Information

Serial Number86895971
Word MarkPFIZER CENTERONE
Filing DateWednesday, February 3, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, February 28, 2023
Registration Number5157646
Registration DateTuesday, March 7, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 21, 2016

Trademark Statements

Goods and ServicesContract manufacturing services in the field of pharmaceuticals and pharmaceutical delivery systems
Pseudo MarkPFIZER CENTER ONE

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateMonday, February 8, 2016
Primary Code040
First Use Anywhere DateSunday, November 11, 2007
First Use In Commerce DateSunday, November 11, 2007

Trademark Owner History

Party NamePfizer Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Tuesday, March 28, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 28, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 28, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 28, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 28, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 28, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, February 28, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, February 28, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, August 11, 2022TEAS SECTION 8 & 15 RECEIVED
Monday, March 7, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, May 18, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Thursday, March 19, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, March 19, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 19, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, March 19, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 19, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 19, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 7, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, January 31, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, January 30, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sunday, January 29, 2017STATEMENT OF USE PROCESSING COMPLETE
Tuesday, January 10, 2017USE AMENDMENT FILED
Saturday, January 28, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 10, 2017TEAS STATEMENT OF USE RECEIVED
Tuesday, August 16, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 21, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 21, 2016PUBLISHED FOR OPPOSITION
Wednesday, June 1, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 27, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 27, 2016EXAMINER'S AMENDMENT ENTERED
Wednesday, April 27, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, April 27, 2016EXAMINERS AMENDMENT E-MAILED
Wednesday, April 27, 2016EXAMINERS AMENDMENT -WRITTEN
Tuesday, April 26, 2016ASSIGNED TO EXAMINER
Tuesday, February 9, 2016NOTICE OF PSEUDO MARK E-MAILED
Monday, February 8, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 6, 2016NEW APPLICATION ENTERED

Related Keywords

centerone pfizer pharmaceutical delivery systems pharmaceuticals field manufacturing services contract